Image-guided therapy developer IMRIS said it has received a notice of delisting from the Nasdaq Stock Market.
As a result, trading in the firm's common shares will be suspended at the opening of business on June 4. IMRIS said Nasdaq based its decision on concerns regarding the May 26 announcement that IMRIS has filed for Chapter 11 bankruptcy protection. The decision was also based on concerns regarding the residual equity interest of the existing listed securities holders, as well as the firm's ability to sustain compliance with all requirements for continued listing on the Nasdaq exchange.